A Q&A On Comprehensive Genomic Profiling in rare cancers and cancer of unknown primary.

3 Views
administrator
administrator
07/10/23

A Q&A with TargetCancer Foundation on Comprehensive Genomic Profiling and its relevance in rare cancers and cancer of unknown primary, as well as its incorporation in the TRACK Study.

Featuring:
Jim Palma, Executive Director, TargetCancer Foundation
Dr. Prasanth Reddy, VP of Medical Affairs, Foundation Medicine

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next